COVID-19 Vaccine Corporation Partners With The University Of Queensland
Tuesday, 23 February 2021, 1:10 pm AUCKLAND: COVID-19 Vaccine Corporation (CVC) has joined forces with the University of Queensland in its vaccine production efforts. After halting development of its spike protein based candidate in December, CVC continues to progress development of its proprietary T-cell vaccine. Its T-cell vaccine is designed to work with other existing vaccines in order to improve efficacy, lengthen immunity time and to protect against all new variants for the SARS-Cov-2 virus, including those from Britain and South Africa. CVC’s efforts and new partnership are particul...